Louise Dunnett

Louise joined i04-1 in November 2018, after completing her PhD in the Prischi Group at Essex University where she studied a cell survival pathway responsible for the development of chemo-resistance in Small Cell Lung Cancer. As part of her PhD she used the XChem facility at Diamond to screen hnRNP A1 as a novel drug target. Prior to this she worked for OncImmune Ltd (Nottingham, UK) producing commercially available ELISA-based blood tests for the early detection of various cancers, in particular developing high throughput methods for screening protein production buffers. Louise was awarded an MSc in Cancer Immunology and Biotechnology at Nottingham University and before that gained a BSc in Molecular Biology from Sheffield University. At present Louise is working on ways to increase the throughput of samples on i04-1 and is also investigating options for the new beamline in preparation for the Diamond II upgrade.